New approach methodologies (NAMs) are actively being developed to supplement or replace in vivo testing as part of the drive towards the three Rs of replacement, reduction and refinement of animal experiments. This article provides an overview of NAMs and their recent developments in biological safety assessments, with an emphasis on the application to medical devices.